Industry news

• AI-supported spectroscopy delivers superior pharmaceutical packaging QC

  03 October 2023 Catherine Eckford / European Pharmaceutical Review

  A combination of mid-infrared spectroscopy and artificial intelligence (AI) achieved excellent prediction capability for inline pharmaceutical packaging content verification, a study has shown.

• Lymphoma maintenance therapy delivers promise in CTCL

  03 October 2023 Catherine Eckford / European Pharmaceutical Review

  One of the largest clinical trials in cutaneous T-cell lymphoma (CTCL) to date could change current clinical practice, new data shows.

• To help drugs withstand the 'white hot heat' of human trials, scientists model the preclinic after the clinic

  02 October 2023 Helen Floersh / FierceBiotech

  It’s no secret that most drugs that work in mice fail to work in men (and women). Yet thousands of animal lives and taxpayer dollars are spent on preclinical research that, in the end, offers little more than false hope. A new method for conducting preclinical studies could help change that.

• The FAS implemented 864 new drug prices in 2022

  02 October 2023 GxPNews

  In 2022, FAS conducted an economic analysis of more than 9,000 drug prices. More than 7,600 prices were analyzed in relation to registration and re-registration, more than 1,200 – in relation to setting prices for defective drugs. In total, over the past year, the FAS established 864 economically justified prices for drugs. Daria Starykh, Deputy Head of the Health Control Department of the Federal Antimonopoly Service of Russia, shared this exciting announcement at the XI Partnership event “Russian Medicines – Towards Interdisciplinary Dialogue” on Friday, September 22.

• Proposed chemical ban would cause EU drug manufacturing to 'grind to a halt,' trade group warns

  29 September 2023 Fraiser Kansteiner/FiercePharma

  A proposed restriction on the use of fluorinated substances in Europe would have an “irredeemable impact” on the continent’s life sciences sector, the European Federation of Pharmaceutical Industries and Associations (EFPIA) warns.

• Rospotrebnadzor reports: over 18 million people in Russia received the influenza vaccine

  29 September 2023 GxPNews

  Over 1.2 million cases of influenza and SARS have been reported as of week 38 in 2023. The anticipated increase in cases is linked to the arrival of autumn, specifically the onset of cold weather across Russia, along with a rise in cooperative endeavors. 26 regions of Russia recorded the highest rate of infection.

• Murashko stated that the medical care pertaining to organ transplantation is expanding, both in terms of volume and accessibility

  28 September 2023 GxPNews

  According to Russian Health Minister, Mikhail Murashko, the accessibility of organ transplantation services is increasing for Russian citizens. At the VI Russian National Congress on “Transplantation and Organ Donation,” the speaker emphasized the significant progress in providing vital healthcare services across Russia. 

• Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen

  28 September 2023 Satoshi Sugiyama and Pratik Jain / Reuters

  Japan's Eisai (4523.T) said on Monday its Alzheimer's treatment developed with Biogen (BIIB.O), Leqembi, was approved by the country's health ministry, making it the second nation after the United States to clear its use.

• Rospotrebnadzor reports: over 18 million people in Russia received the influenza vaccine

  27 September 2023 GxPNews

  Over 1.2 million cases of influenza and SARS have been reported as of week 38 in 2023. The anticipated increase in cases is linked to the arrival of autumn, specifically the onset of cold weather across Russia, along with a rise in cooperative endeavors. 26 regions of Russia recorded the highest rate of infection.

• Belarus has received the initial shipment of cancer diagnostic generators from Rosatom

  27 September 2023 GxPNews

  Rosatom supplied the first batch of technetium-99m GT-5K generators for medical institutions of the Republic of Belarus. This was reported by the press service of JSC All-Regional Association Isotope (part of the Health Technologies division of Rosatom).